Mycophenolate Mofetil (MMF) and Zenapax (DZB) Peter Gottlieb, BDC &VMR (<8 weeks off diagnosis) Mycophenolate Mofetil (MMF) and Zenapax (DZB) Peter Gottlieb, BDC &VMR (<8 weeks off diagnosis) MMF protects BB rats from developing DM MMF effective in a number of autoimmune conditions and in transplantation DZB effective as part of transplantation regimens IL2-R+ cells increased at dx of DM, harbor autoreactive T cells (mouse and man) known toxicities of drugs are low NO EFFECT NEW ONSET DIABETES TRIALNET STUDY
{}